mRNA Cancer Vaccine Halves Melanoma Recurrence Risk in Groundbreaking Trial

Medicine & Technology Jun 05, 2024

Groundbreaking trial shows mRNA cancer vaccine halves melanoma recurrence risk. Learn about this revolutionary advancement in cancer treatment. Read more!

Novel Skin Cancer Vaccine Clinical Trial Shows Promising Results As Initial Data Reveals Recurrence, Death Risk Cut By 49%

Jan 05, 2024

When combined with KEYTRUDA, the skin cancer vaccine was observed to demonstrate promising results. Read to learn more.

mRNA Nanoparticle Characterization: Novel Method Uses AF4 and SAXS Techniques in Determining Size-Dependent Features of Nanomedicines

Dec 20, 2023

A new and versatile approach was introduced by researchers for obtaining size-resolved characterization of mRNA nanoparticles. Learn more about it in this article.

COURIER RNA Export System Enables Researchers To Follow Cellular Processes, Shows Potential in Allowing New Therapeutic Strategies

Aug 29, 2023

A team of Caltech researchers developed a synthetic RNA export system which helps unveil the dynamic lives of cells and offers new insights into therapeutics. Find out more about it in this article.

SCALAR Microchip Allows Mass-Scale Production of mRNA Lipid Nanoparticles, Revolutionizes the Manufacturing of Vaccines and Therapeutics

Aug 25, 2023

A group of researchers developed a scalable microfluidics which can accelerate the production of mRNA-based lipid nanoparticles vaccines and therapeutics at the small and large scale. Learn more about it in this article.

Breakthrough in Cancer Treatment Induces the Cells To Commit Suicide With Self-Produced Toxin

Jul 06, 2023

Israeli researchers developed a method of treating cancer where the cells are induced to make toxic protein that will eventually kill them. Learn more about it in this article.

Printable Vaccine Patches? Mobile Printer Could Help Scale Up Production, Boost Accessibility to mRNA Doses

Apr 26, 2023

These mobile vaccine printers may enable on-demand vaccine production in the future. Read to learn more.

Novel Nanoparticles Can Deliver mRNA in the Lungs to Aid in Gene-editing With a Potential of Developing Treatment for Cystic Fibrosis, Other Lung Diseases

Apr 03, 2023

Novel nanoparticles can perform gene-editing in the lungs, potentially developing treatments for lung diseases. Read the article to learn more.

HIV Prevention: Researchers Suggest Identifying Antibodies and Human Genes as New Strategy for Making Effective Vaccine Against the Disease

Oct 04, 2022

Researchers suggest that initial steps in a vaccine approach aim to prompt the development of antibodies. Read to know more about this strategy.

Novavax COVID-19 Vaccine Now FDA Approved for People 18 and Above, Protein-Based Jab Has Less Side Effects

Jul 15, 2022

The FDA authorized Novavax to inject its COVID-19 vaccine into individuals aged 18 years old and above. Read to know its difference from other similar vaccines.

Deciphering RNA 3D Structure Now Possible with Novel Technique

May 03, 2022

Experts have long been unable to crack the mysteries of RNA molecules, their structures, and their function. Read on to find out how a team of researchers from Harvard University was able to develop a novel technique that allows the 3D analysis of RNA molecules.

People Previously Infected with COVID-19 Less Likely to be Reinfected with the Virus, Providence Study Reveals

Apr 21, 2022

A study showed that people with previous COVID-19 infection are protected from reinfection from the same virus. Find out what natural immunity offers here.

Cardiovascular Treatment: COVID-19 Vaccine mRNA Technology Could Regenerate Heart Muscles After Cardiac Attack, Study Says

Apr 17, 2022

Scientists found the world's first cure for heart attacks using the same technology used in COVID-19 vaccines. Read on to learn further details.

Moderna to Develop 3 New Vaccines Including mRNA Treatment for Cancer and Herpes

Feb 21, 2022

Moderna announced to create three new mRNA vaccines to treat herpes, shingles, and cancer.

COVID-Flu Vaccine: How Soon Can We Get This Combined Booster Shot Against Coronavirus, Influenza, RSV, of Moderna?

Jan 18, 2022

Vaccine maker Moderna recently said it is hoping to sell a combined booster jab for infectious diseases such as COVID-19, influenza, and a common respiratory virus known as RSV.